Please provide your email address to receive an email when new articles are posted on . He continued, “We wanted to see if it is possible to reduce the dose of adalimumab (by extending the duration ...

AbbVie GK, Eisai Co., Ltd., and its subsidiary EA Pharma Co., Ltd. announced the additional approval for a new dosing regimen of Humira Pre-filled Syringe 40 mg/0.8 ml for Subcutaneous Injection ...

Celltrion USA is offering an 80 mg dose of Yuflyma (adalimumab-aaty), a high-concentration (100mg/ml) and citrate-free formulation of Humira (adalimumab) biosimilar, in the United States. Yuflyma is ...

It is an exciting time to be a medical dermatologist, with the ongoing development of numerous safe and effective systemic treatments for several complex medical dermatologic diseases. For example, ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

As with other medications, Humira can interact with certain other drugs. It can also interact with some vaccines. An interaction occurs when one substance causes another substance to have a different ...

Credit: Getty Images. Amjevita is supplied as a 40mg/0.8mL single-dose prefilled SureClick autoinjector, and as 20mg/0.4mL and 40mg/0.8mL single-dose prefilled syringes. The Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the seventh biosimilar to adalimumab, adalimumab-aqvh, for all eligible indications of the ...

Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis. The approval for Idacio was based on a review of data that showed similar pharmacokinetics, efficacy, safety, ...